|
|
|
|
Submitted on July 28, 2007
Revised on February 12, 2008
Accepted on March 6, 2008
q and Cooperation between ERK1/2 and Rho Kinase Signalling Pathways
*Centre for Respiratory Research, University College London, London WC1E 6JF, United Kingdom;
Caden Biosciences, Madison, WI 53711
Monitoring Editor: Mark Ginsberg
Uncontrolled activation of the coagulation cascade following tissue injury has been implicated in both inflammation and tissue fibrosis. Thrombin exerts pluripotent cellular effects via its high-affinity receptor, proteinase activated receptor-1 (PAR1) and signaling via G
i/o, G
q or G
12/13. Activation of PAR1 on fibroblasts, a key effector cell in fibrosis, results in the induction of several mediators, including the potent monocyte and fibrocyte chemoattractant CCL2. The aim of this study was to identify the G-protein and signaling pathway involved in PAR1-mediated CCL2 production and release. Using a novel PAR1 antagonist which blocks the interaction between PAR1 and G
q, we report for the first time that PAR1 coupling to G
q is essential for thrombin-induced CCL2 gene expression and protein release in murine lung fibroblasts. We further demonstrate that these effects are mediated via the cooperation between ERK1/2 and Rho kinase signaling pathways: a calcium-independent PKC, c-Raf and ERK1/2 pathway was found to mediate PAR1-induced CCL2 gene transcription; whereas PLC, calcium-dependent PKC and Rho kinase pathway influences CCL2 protein release. We propose that targeting the interaction between PAR1 and G
q mayallow us to selectively interfere with PAR1 proinflammatory and profibrotic signaling, while preserving the essential role of other PAR1-mediated cellular responses.